A subsequent larger study with AD patients confirmed these findings, showing no significant effects on CSF biomarkers including Aβ40, Aβ42, Aβ42/Aβ40, total tau, p181tau And Aβ 42/total tau ratios [311]. This evidence concerns the gene MAPT and Alzheimer disease.